- Open Access
Titanium peroxide nanoparticles enhanced cytotoxic effects of X-ray irradiation against pancreatic cancer model through reactive oxygen species generation in vitro and in vivo
© The Author(s). 2016
- Received: 3 December 2015
- Accepted: 2 July 2016
- Published: 7 July 2016
Biological applications of nanoparticles are rapidly increasing, which introduces new possibilities to improve the efficacy of radiotherapy. Here, we synthesized titanium peroxide nanoparticles (TiOxNPs) and investigated their efficacy as novel agents that can potently enhance the effects of radiation in the treatment of pancreatic cancer.
TiOxNPs and polyacrylic acid-modified TiOxNPs (PAA-TiOxNPs) were synthesized from anatase-type titanium dioxide nanoparticles (TiO2NPs). The size and morphology of the PAA-TiOxNPs was evaluated using transmission electron microscopy and dynamic light scattering. The crystalline structures of the TiO2NPs and PAA-TiOxNPs with and without X-ray irradiation were analyzed using X-ray absorption. The ability of TiOxNPs and PAA-TiOxNPs to produce reactive oxygen species in response to X-ray irradiation was evaluated in a cell-free system and confirmed by flow cytometric analysis in vitro. DNA damage after X-ray exposure with or without PAA-TiOxNPs was assessed by immunohistochemical analysis of γ-H2AX foci formation in vitro and in vivo. Cytotoxicity was evaluated by a colony forming assay in vitro. Xenografts were prepared using human pancreatic cancer MIAPaCa-2 cells and used to evaluate the inhibition of tumor growth caused by X-ray exposure, PAA-TiOxNPs, and the combination of the two.
The core structures of the PAA-TiOxNPs were found to be of the anatase type. The TiOxNPs and PAA-TiOxNPs showed a distinct ability to produce hydroxyl radicals in response to X-ray irradiation in a dose- and concentration-dependent manner, whereas the TiO2NPs did not. At the highest concentration of TiOxNPs, the amount of hydroxyl radicals increased by >8.5-fold following treatment with 30 Gy of radiation. The absorption of PAA-TiOxNPs enhanced DNA damage and resulted in higher cytotoxicity in response to X-ray irradiation in vitro. The combination of the PAA-TiOxNPs and X-ray irradiation induced significantly stronger tumor growth inhibition compared to treatment with either PAA-TiOxNPs or X-ray alone (p < 0.05). No apparent toxicity or weight loss was observed for 43 days after irradiation.
TiOxNPs are potential agents for enhancing the effects of radiation on pancreatic cancer and act via hydroxyl radical production; owing to this ability, they can be used for pancreatic cancer therapy in the future.
- Titanium peroxide
- Reactive oxygen species
- Pancreatic cancer
Pancreatic cancer is a highly lethal disease that is often diagnosed only in the advanced stage. It is the fourth most common cause of cancer-related deaths in the United States, causing 40,560 deaths annually . Moreover, the 5-year survival rate of pancreatic cancer patients is approximately 3-7 % after diagnosis [1, 2]. Locally advanced pancreatic cancer is also notoriously resistant to many types of cytotoxic chemotherapy and radiotherapy . As a result, there are currently no effective therapies for pancreatic cancer, and novel strategies need to be explored.
The biological application of nanoparticles (NPs) is rapidly increasing in nanotechnology and introduces new possibilities for the diagnosis and treatment of human cancers [4–6]. NPs have been used in many different areas of radiation oncology, including radiosensitization . Nano-sized titanium dioxide (TiO2) is one of the most widely produced nanoparticles. TiO2 is poorly soluble and has been used in numerous applications as a food colorant, or as a white pigment in a number of products including cosmetics, medicines, and pharmaceutical products [8, 9]. Rutile and anatase are the two major crystalline forms of TiO2. The photocatalytic activity and cytotoxicity of anatase TiO2 nanoparticles (TiO2NPs) are higher than those of the rutile forms [10, 11]. Recently, TiO2NPs have been used in the phototherapy of malignant cells and are regarded as potential photosensitizing agents for photodynamic therapy because they exert unique phototoxic effects upon ultraviolet (UV) irradiation [12–16]. Despite the promising effects of UV-activated TiO2NPs, this strategy seems to be ineffective in treating many cancers and is difficult to apply clinically for two major reasons. First, UV light cannot penetrate the human body to reach internal organs such as the gastrointestinal system, liver, and pancreas, thus limiting the application of this technique to superficial tumors . Second, the UV-mediated production of reactive oxygen species (ROS) occurs for a very short duration and is insufficient to provide a continuous and prolonged cancer-killing effect . Radiotherapy using X-rays is known to be effective in various cancer treatments. However, to our knowledge, there are few reports investigating whether or not TiO2NPs can enhance the effects of X-ray irradiation . In addition, the properties of TiO2NPs seem to be insufficient to render them useful as radiosensitizers. Wang et al. demonstrated that the potential biological effects of TiO2NPs depend on their size, crystal phase, surface coating, and chemical composition . Therefore, certain modifications may be necessary to make TiO2NPs suitable for use as agents that enhance the effects of radiation.
Chemical reactions between hydrogen peroxide and TiO2 have been widely investigated [21, 22], but the effects of these reactions on the properties of TiO2NPs in response to X-ray irradiation have not been clarified. In this study, we investigated the properties of titanium peroxide nanoparticles (TiOxNPs) to determine whether the TiOxNPs might be useful as potential agents to enhance the effects of radiation against a human pancreatic cancer model in vitro and in vivo.
Preparation of TiOxNPs
Transmission electron micrography (TEM), dynamic light scattering (DLS), and X-ray absorption fine structure (XAFS) analyses
The size and morphology of the PAA-TiOxNPs were studied using a transmission electron microscope (JEM-1200EX, JEOL Ltd., Tokyo, Japan) as described previously . The transmission electron micrographs were recorded at an acceleration voltage of 80 kV. DLS was conducted using a Malvern Zetasizer Nano ZS to estimate the hydrodynamic diameter of the PAA-TiOxNPs.
The XAFS measurements in fluorescence mode were performed around a Ti K-edge energy region at BL9A at the Photon Factory, KEK, Japan. Synchrotron radiation from a 2.5 GeV storage ring was monochromatized using a Si (111) double crystal monochromator modified to 2 × 1 mm2 with slits and counted using an ion chamber for I0 and a Lytle-type detector for fluorescence X-rays. Higher harmonic radiation was removed using an Rh-Ni-coated mirror. The TiO2NP and PAA-TiOxNP suspensions were put into polyethylene bags for the XAFS measurements. TiO2 minerals (rutile and anatase) on Scotch tape were measured as standard titanium materials with known chemical compositions and crystal structures.
Cell culture and establishment of the animal models
The MIAPaCa-2 human pancreatic cancer cell line was obtained from the American Type Culture Collection (Rockville, MD, USA) and maintained in RPMI-1640 medium. Male BALB/c nude mice (body weight: 20–22 g) were purchased from CLEA Corporation (Tokyo, Japan). The nude mice were maintained in specific pathogen-free animal care facilities under isothermal conditions with regular photoperiods. All animal experiments were approved by the Institutional Animal Care and Use Committee (Permission number: 100605R1) and performed according to Kobe University Animal Experimentation Regulations.
X-ray irradiation was performed using a MBR-1505R2 (Hitachi, Tokyo, Japan) at a voltage of 150 kV and a current of 5 mA with a 1-mm-thick aluminum filter (0.5 Gy/min at the target). Prior to each experiment, the mice were anesthetized using an intraperitoneal administration of somnopentyl (0.1 mg/g body weight) and were then put to sleep under anesthesia and immobilized in a customized harness that exposed the hind leg while shielding the remainder of the body with lead during irradiation.
Quantification of ROS generation from the NPs in response to X-ray irradiation in a cell-free system was performed using 3’-(p-aminophenyl) fluorescein (APF; Sekisui Medical Co. Ltd., Tokyo, Japan), which fluoresces mainly in response to hydroxyl radicals . APF (5 μM) was added to different concentrations of the suspensions of TiOxNPs, PAA-TiOxNPs, and TiO2NPs prepared using 96-well plates. Each plate was then exposed to different doses of X-ray radiation. The APF signal was measured using a multi-well plate reader (Fluoroskan Ascent FL, Thermo Fisher Scientific Inc., MA, USA) at excitation/emission wavelengths of 490/515 nm. To determine whether the increase in APF fluorescent signals was caused by ROS generation, antioxidants such as vitamin C (1 mM) or glutathione (1 mM) were added as ROS scavengers. The amount of hydrogen peroxide was measured in response to carboxy-2′, 7’-dichlorofluorescein (C-H2DCF; Molecular Probes, Inc., Eugene, OR, USA). C-H2DCF (50 μM) was added to suspensions of TiOxNPs, which were then exposed to X-ray radiation. The fluorescent signal was measured at excitation/emission wavelengths of 485/612 nm.
The production of intracellular ROS including hydrogen peroxide, hydroxyl radicals, and superoxide anions was evaluated using a fluorescence activated cell sorting (FACS Calibur; Becton-Dickinson, NJ, USA). The MIAPaCa-2 cells were treated with 0.1 % w/v PAA-TiOxNPs for 1 h at 37 °C with or without 30 Gy X-ray irradiation. For 30 min, the cells were stained with 10 μM APF, 50 μM C-H2DCF, and 50 ng/mL hydroethidium (HE; Molecular Probes, Inc., OR, USA) per sample to detect cellular hydroxyl radicals, hydrogen peroxide, and superoxide anions, respectively .
Detection of DNA damage and colony forming assay in vitro
Induction of deoxyribonucleic acid (DNA) damage was investigated by the detection of phosphorylated histone 2AX (γ-H2AX) foci using immunocytochemistry. MIAPaCa-2 cells were subcultured on 35-mm dishes. The cells were treated with 0.15 % w/v PAA-TiOxNPs for 1 h and/or 5 Gy of X-ray irradiation. After the treatment, the cells were fixed in 4 % paraformaldehyde in phosphate buffered saline (PBS) for 20 min, permeabilized with 0.1 % Triton X-100 in PBS for 5 min, and blocked in 5 % bovine serum albumin in PBS for 60 min. Cells were incubated with 1:200 rabbit anti γ-H2AX antibody (Cell Signaling Technology, MA, US) overnight at 4 °C. Then, the cells were incubated with 1:20 tetramethyl rhodamine isothiocyanate (TRITC)-conjugated anti-rabbit secondary antibody (Dako, Glostrup, Denmark) for 90 min at room temperature. Cell nuclei were stained with 4’, 6-diaidino-2-phenylindole (DAPI). Stained cells were observed using a fluorescence microscope (BZ-9000, KEYENCE, Osaka, Japan). Cells expressing nuclear γ-H2AX foci were then counted manually from 100 cells for each treatment, and the data were presented as the mean ± standard deviation (SD) from 3 fields for each section .
To evaluate whether the PAA-TiOxNPs might enhance the effects of radiation in vitro, a colony forming assay was performed. MIAPaCa-2 cells (1 × 106) were exposed to 0.15 % w/v PAA-TiOxNPs for 30 min, and then they were treated with 0, 3, or 5 Gy of X-ray irradiation. The treated cells were counted and replated onto a new 10-cm tissue culture dish with fresh medium not containing PAA-TiOxNPs. The cells were incubated for 10 days until the cell population completed colony formation. After fixing and staining, colonies consisting of more than 50 cells were counted and the surviving fractions were calculated based on the survival of non-irradiated cells.
Tumor growth inhibition of PAA-TiOxNPs combined with X-ray radiation
MIAPaCa-2 cells (2 × 106) were injected subcutaneously into the hind legs of the BALB/c nude mice as described previously . The tumor was expected to enlarge to be palpable, i.e., approximately 6–10 mm in the longest axis and 5–7 mm in the shortest axis, with skin thickness by 7 days post injection. Tumor volume was calculated using the formula L × W2/2, where L is the longest axis and W is the shortest axis of the tumor. Using this formula, the tumor volume was approximately 100–200 mm3 on the treatment day. The mice were stratified into 4 subgroups consisting of 3 mice each: untreated, PAA-TiOxNPs alone, X-rays alone, and X-rays combined with PAA-TiOxNPs. The mice were given an intra-tumoral injection of 150 μL of an 8.7 % w/v PAA-TiOxNP suspension with or without a single dose of 5 Gy of X-ray irradiation approximately 1 h after the injection. To inject a sufficient amount of the PAA-TiOxNP suspension while keeping the suspension as homogeneous as possible, we injected 150 μL of the PAA-TiOxNP suspension into each tumor. The tumor size, body weight, and health of the mice were measured for 43 days after the initial treatment (for a total of 50 days after the injection) .
Mechanism of tumor growth inhibitory effect by PAA-TiOxNPs combined with X-ray irradiation
At 24 h after treatment, the tumors were excised, fixed in 10 % formalin, and embedded in paraffin sections (4-μm-thick). The samples were stained using hematoxylin and eosin (H-E).
Induction and maintenance of DNA damage in the tumor by X-ray radiation with or without PAA-TiOxNPs was evaluated by detection of γ-H2AX immunoreactivity using a fluorescence microscope (BZ-9000, Keyence, Osaka, Japan). Sections were counterstained with DAPI. Positive γ-H2AX signals in the nucleus were visually counted in 300 cells for each treatment. The number of γ-H2AX foci was calculated by averaging the number of the positive cells from 3 fields for each section. Induction of apoptosis was also evaluated using the terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling (TUNEL) assay (Roche Applied Science, Indianapolis, IN, US) . Positive TUNEL signals were evaluated in 100 cells for each treatment, and the number of apoptotic cells was calculated by averaging the number of positive TUNEL signals from 6 fields for each section.
Data are expressed as the mean ± SD. Comparisons were performed using Student’s t-test, and differences were considered significant at the 95 % confidence level (p < 0.05).
Successful preparation of TiOxNPs
Considering the enhanced permeability and retention effect, we aimed to prepare nanoparticles with a size of less than 100 nm. The PAA-TiOxNPs were found to be approximately 50–70 nm in diameter, as determined using TEM (Fig. 1b). Consistent with the TEM images, the size of the PAA-TiOxNPs, as determined using DLS, was approximately 50–100 nm with a narrow unimodal size distribution (Fig. 1c).
The crystalline structures of TiO2NPs and PAA-TiOxNPs with or without X-ray radiation (16 Gy) were analyzed using XAFS (Fig. 1d). No change in the coordination environment was observed around the Ti ion from the original anatase-type TiO2NPs until the PAA-TiOxNPs were irradiated with X-rays. From this observation, it was concluded that the PAA-TiOxNPs preserve the anatase structure of TiO2NPs in the core structures.
ROS-generating effect of TiOxNPs under X-ray irradiation
To assess intracellular ROS production by PAA-TiOxNPs with X-ray radiation, the amount of hydroxyl radicals, hydrogen peroxide, and superoxide anions was measured using FACS. In cells treated with PAA-TiOxNPs combined with X-ray radiation, the hydroxyl radical levels increased by more than 2 fold and the hydrogen peroxide levels increased by more than 1.6 fold in comparison to the control, whereas the superoxide levels did not increase (Fig. 2d).
Cytotoxic effects of PAA-TiOxNPs under X-ray irradiation in vitro
Tumor growth inhibitory effects of PAA-TiOxNPs combined with X-ray irradiation in vivo
No immediate toxic reaction was observed in the mice injected with the PAA-TiOxNPs. No mice died during the 43-day observation period and none showed any apparent loss of body weight (Fig. 4c). These findings suggest that the PAA-TiOxNPs themselves do not have any apparent toxicity at the effective dose applied during this period.
Mechanisms underlying tumor growth inhibitory effects in vivo
To our knowledge, this is the first report to show that TiOxNPs synthesized from anatase-type TiO2NPs can produce hydroxyl radicals under X-ray irradiation. This property resulted in remarkable tumor growth inhibition in a human pancreatic carcinoma xenograft.
The core of the PAA-TiOxNPs remained the same as that of TiO2NPs with the original anatase structure (Fig. 1d), whereas the property of the TiOxNPs to produce ROS in response to X-ray irradiation was different from that of TiO2NPs (Fig. 2a). Based on these findings and according to the process used to synthesize the TiOxNPs, it was speculated that surface of the TiOxNPs was different from that of TiO2NPs, and it seemed to be peroxidized by hydrogen peroxide. The acquired property of the TiOxNPs was first examined under cell-free conditions (only water and TiOxNPs) using APF. Because the APF reaction is specific to hydroxyl radicals, peroxynitrite anion, and hypochlorite anion , the major ROS generated from the TiOxNPs and PAA-TiOxNPs in response to X-ray irradiation was identified as hydroxyl radicals. Next, this finding was further investigated in cells using FACS (Fig. 2d). The results indicated that the hydroxyl radical and hydrogen peroxide levels increased, whereas the levels of superoxide anions did not. These results were consistent with those observed in the cell-free system. Cellular redox homeostasis is maintained by the balance between the generation and elimination of ROS. Exogenous agents that increase ROS generation or decrease antioxidant capacity will shift the redox balance and result in an overall increase in the ROS levels, which may induce cell death when above a cellular tolerability threshold . Cancer cells would be more dependent on the antioxidant system and more vulnerable to further oxidative stress induced by exogenous ROS-generating agents or compounds that inhibit the antioxidant system. Combinations of ROS-generating agents with X-ray radiation, which is capable of abrogating cellular antioxidant systems, are likely to have an additive or synergistic cytotoxic effect. From our determination that the combination of X-ray irradiation and PAA-TiOxNPs induced higher amounts of ROS and DNA damage in vitro, it was at least speculated that the PAA-TiOxNPs might act as ROS-generating agents in response to X-ray irradiation in the cells. The mechanism might affect the combination effect observed in the colony forming assay (Fig. 3d).
It was noteworthy that the use of PAA-TiOxNPs in combination with X-ray radiation induced tumor growth inhibition in vivo. The effect of the combination therapy was significantly greater than that of each of the single treatments (Fig. 4a, b), thus indicating a potential synergistic effect. However, although our results indicate a potential role for the production of hydroxyl radicals from the PAA-TiOxNPs, the sites for ROS production (inside the cells, or on the outer membrane, or both) remain unclear. In the histochemical analyses, the PAA-TiOxNPs appeared to accumulate inside the cells (Fig. 5a), thus suggesting that the increase in ROS levels according to the Fenton reaction may occur inside the cells. Halliwell et al. previously reported that the hydroxyl radical could be produced via the Fenton reaction in the presence of biological free iron and superoxide, leading to oxidative damage . In our experimental setting, a small radiation dose (5 Gy) was effective for induction of apoptosis and tumor shrinkage; larger doses or multiple doses will probably have greater effects. The use of the combination of PAA-TiOxNPs with X-ray radiation in vivo appeared to be effective for inhibiting tumor growth.
Metal nanoparticles have unique characteristics such as particle size, high surface-to-volume ratio, broad optical properties, and facile surface chemistry [34, 35]. Radiosensitization of gold nanoparticles (GNPs) occurs because of the high absorbance of gold and the resulting deposition of energy in surrounding tissues from photoelectrons and auger electrons, and because of the generation of ROS [36–39]. Compared to these findings for GNPs, fewer data appear to be available for the applications of TiOxNPs, and multiple aspects of TiOxNPs still need to be evaluated. Although our results indicate that TiOxNPs have potential for use as agents that enhance the effects of radiation, further research on this property of TiOxNPs in comparison to GNPs is necessary.
Our study has a few limitations. The route of administration was intra-tumoral injection, and the effects of intravenous injection were not tested. There are several reports indicating that intravenously injected GNPs can readily extravasate into advanced brain tumors, leading to increased survival of mice with advanced glioblastoma treated with radiotherapy plus GNPs [40, 41]. Therefore, systemic intravenous administration of PAA-TiOxNPs may induce an additional effect. Further evaluation is warranted in this regard. On the contrary, some studies have reported protracted elimination of GNPs from the liver [42, 43], and other studies have reported the nephrotoxicity of GNPs [44, 45]. Although no change in the weight of the mice was observed in our experimental setting, larger amounts of PAA-TiOxNPs seem to be necessary in case of systemic administration, and toxicity, including acute liver or renal toxicity, will need to be carefully evaluated.
In conclusion, TiOxNPs showed remarkable ROS production upon X-ray irradiation. PAA-TiOxNPs were effective in a mouse model using engrafted human pancreatic cancer cells. Although future studies will be required to confirm the therapeutic effects and potential toxicity of nanoparticles, our study shows that TiOxNPs are promising agents for enhancing the effects of radiation in pancreatic cancer therapy.
APF, 3’-(p-aminophenyl) fluorescein; C-H2DCF, carboxy-2′, 7’-dichlorofluorescein; DAPI, 4′, 6-diaidino-2-phenylindole; DLS, dynamic light scattering; DNA, deoxyribonucleic acid; FACS, fluorescence activated cell sorting; GNPs, gold nanoparticles; H-E, hematoxylin and eosin; HE, hydroethidium; NPs, nanoparticles; PAA, polyacrylic acid; PBS, phosphate buffered saline; ROS, reactive oxygen species; SD, standard deviation; TEM, transmission electron micrography; TiO2, titanium dioxide; TiO2NPs, titanium dioxide nanoparticles; TiOxNPs, titanium peroxide nanoparticles; TUNEL, terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling; UV, ultraviolet; XAFS, X-ray absorption fine structure; γ-H2AX, phosphorylated histone 2AX
The authors thank Izumi Takayama (Division of Radiation Oncology, Kobe University) for assistance with in vitro and in vivo studies.
This work was supported by a Health Labor Sciences Research Grant of the Ministry of Health, Labor and Welfare of the Japanese government (AK), and Grant-in-Aid (No.25670535 to RS; No. 25420831 to CO) for Exploratory Research from the Ministry of Education, Culture, Sports, Science and Technology.
Availability of data and materials
The datasets supporting the conclusions of this article are included within the article and its Additional file 1.
CO, RS, and AK contributed to the study design and concept. MN, KM, ZT, and HA performed practical work and acquired the data. MN, CO, KS, YN, and CN participated in the analysis and interpretation of the data. TT, MU, SO, KS, and ST contributed to administrative, technical, and material support. MN and RS contributed to manuscript writing. All of the authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
Ethics approval and consent to participate
All animal experiments in this study were approved by the Institutional Animal Care and Use Committee (Permission number: 100605R1) and performed according to Kobe University Animal Experimentation Regulations.
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29.View ArticlePubMedGoogle Scholar
- Sharma C, Eltawil KM, Renfrew PD, Walsh MJ, Molinari M. Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990–2010. World J Gastroenterol. 2011;17:867–97.View ArticlePubMedPubMed CentralGoogle Scholar
- Goodman KA, Hajj C. Role of radiation therapy in the management of pancreatic cancer. J Surg Oncol. 2013;107:86–96.View ArticlePubMedGoogle Scholar
- Yezhelyev MV, Gao X, Xing Y, Al-Hajj A, Nie S, O’Regan RM. Emerging use of nanoparticles in diagnosis and treatment of breast cancer. Lancet Oncol. 2006;7:657–67.View ArticlePubMedGoogle Scholar
- Kim BY, Rutka JT, Chan WC. Nanomedicine. N Engl J Med. 2010;363:2434–43.View ArticlePubMedGoogle Scholar
- Service RF. Materials and biology: Nanotechnology takes aim at cancer. Science. 2005;310:1132–4.View ArticlePubMedGoogle Scholar
- Wang AZ, Tepper JE. Nanotechnology in radiation oncology. J Clin Oncol. 2014;32(26):2879–85.View ArticlePubMedPubMed CentralGoogle Scholar
- Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Cogliano V, et al. Carcinogenicity of carbon black, titanium dioxide, and talc. Lancet Oncol. 2006;7:295–6.View ArticlePubMedGoogle Scholar
- Lomer MC, Thompson RP, Powell JJ. Fine and ultrafine particles of the diet: influence on the mucosal immune response and association with Crohn’s disease. Proc Nutr Soc. 2002;61:123–30.View ArticlePubMedGoogle Scholar
- Kakinoki K, Yamane K, Teraoka R, Otsuka M, Matsuda Y. Effect of relative humidity on the photocatalytic activity of titanium dioxide and photostability of famotidine. J Pharm Sci. 2004;93:582–9.View ArticlePubMedGoogle Scholar
- Sayes CM, Wahi R, Kurian PA, Liu Y, West JL, Ausman KD, et al. Correlating nanoscale titania structure with toxicity: a cytotoxicity and inflammatory response study with human dermal fibroblasts and human lung epithelial cells. Toxicol Sci. 2006;92:174–85.View ArticlePubMedGoogle Scholar
- Trouiller B, Reliene R, Westbrook A, Solaimani P, Schiestl RH. Titanium dioxide nanoparticles induce DNA damage and genetic instability in vivo in mice. Cancer Res. 2009;69:8784–9.View ArticlePubMedGoogle Scholar
- Reeves JF, Davies SJ, Dodd NJ, Jha AN. Hydroxyl radicals (▪OH) are associated with titanium dioxide (TiO2) nanoparticle-induced cytotoxicity and oxidative DNA damage in fish cells. Mutat Res. 2008;640:113–22.View ArticlePubMedGoogle Scholar
- Xu J, Sun Y, Huang J, Chen C, Liu G, Jiang Y, et al. Photokilling cancer cells using highly cell-specific antibody-TiO2 bioconjugates and electroporation. Bioelectrochemistry. 2007;71:217–22.View ArticlePubMedGoogle Scholar
- Ogino C, Shibata N, Sasai R, Takaki K, Miyachi Y, Kuroda S, et al. Construction of protein-modified TiO2 nanoparticles for use with ultrasound irradiation in a novel cell injuring method. Bioorg Med Chem Lett. 2010;20:5320–5.View ArticlePubMedGoogle Scholar
- Fujishima A, Rao TN, Tryk DA. Titanium dioxide photocatalysis. Photochem Rev. 2000;1:1–21.View ArticleGoogle Scholar
- Cai R, Kubota Y, Shuin T, Sakai H, Hashimoto K, Fujishima A. Induction of cytotoxicity by photoexcited TiO2 particles. Cancer Res. 1992;52:2346–8.PubMedGoogle Scholar
- Blake DM, Maness P-C, Huang Z, Wolfrum EJ, Huang J. Application of the photocatalytic chemistry of titanium dioxide to disinfection and the killing of cancer cells. Sep Purif Methods. 1999;28:1–50.View ArticleGoogle Scholar
- Retif P, Pinel S, Toussaint M, Frochot C, Chouikrat R, Bastogne T, et al. Nanoparticles for radiation therapy enhancement: the key parameters. Theranostics. 2015;5(9):1030–44.View ArticlePubMedPubMed CentralGoogle Scholar
- Wang J, Fan Y. Lung injury induced by TiO2 nanoparticles depends on their structural features: size, shape, crystal phases, and surface coating. Int J Mol Sci. 2014;15(12):22258–78.View ArticlePubMedPubMed CentralGoogle Scholar
- Boonstra AH, Mutsaers CAHA. Adsorption of hydrogen peroxide on the surface of titanium dioxide. J Phys Chem. 1975;79:1940–3.View ArticleGoogle Scholar
- Quinn RC, Zent AP. Peroxide-modified titanium dioxide: a chemical analog of putative Martian soil oxidants. Orig Life Evol Biosph. 1999;29:59–72.View ArticlePubMedGoogle Scholar
- Sánche LD, Taxt-Lamolle SF, Hole EO, Krivokapićb A, Sagstuenb E, Haugen HJ. TiO2 suspension exposed to H2O2 in ambient light or darkness: Degradation of methylene blue and EPR evidence for radical oxygen species. Appl Catal B Environ. 2013;142–143:662–7.View ArticleGoogle Scholar
- Kanehira K, Banzai T, Ogino C, Shimizu N, Kubota Y, Sonezaki S. Properties of TiO2-polyacrylic acid dispersions with potential for molecular recognition. Colloids Surf. 2008;B64:10–5.View ArticleGoogle Scholar
- Srivastava SK, Yamada R, Ogino C, Kondo A. Biogenic synthesis and characterization of gold nanoparticles by Escherichia coli K12 and its heterogeneous catalysis in degradation of 4-nitrophenol. Nanoscale Res Lett. 2013;8(1):70.View ArticlePubMedPubMed CentralGoogle Scholar
- Setsukinai K, Urano Y, Kakinuma K, Majima HJ, Nagano T. Development of novel fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species. J Biol Chem. 2003;278:3170–5.View ArticlePubMedGoogle Scholar
- Sasaki R, Suzuki Y, Yonezawa Y, Ota Y, Okamoto Y, Demizu Y. DNA polymerase gamma inhibition by vitamin K3 induces mitochondria-mediated cytotoxicity in human cancer cells. Cancer Sci. 2008;99(5):1040–8.View ArticlePubMedGoogle Scholar
- Bonner WM, Redoc CE, Dickey JS, Nakamura AJ, Sedelnikova OA, Solier S, et al. γH2AX and cancer. Nat Rev Cancer. 2008;8:957–67.View ArticlePubMedPubMed CentralGoogle Scholar
- Mukubou H, Tsujimura T, Sasaki R, Ku Y. The role of autophagy in the treatment of pancreatic cancer with gemcitabine and ionizing radiation. Int J Oncol. 2010;37(4):821–8.PubMedGoogle Scholar
- Zhang XD, Wu D, Shen X, Chen J, Sun YM, Liu PX, et al. Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy. Biomaterials. 2012;33:6408–19.View ArticlePubMedGoogle Scholar
- Sasaki R, Shirakawa T, Zhang ZJ, Tamekane A, Matsumoto A, Sugimura K, et al. Additional gene therapy with Ad5CMV-p53 enhanced the efficacy of radiotherapy in human prostate cancer cells. Int J Radiat Oncol Biol Phys. 2001;51(5):1336–45.View ArticlePubMedGoogle Scholar
- Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov. 2009;8(7):579–91.View ArticlePubMedGoogle Scholar
- Halliwell B, Gutteridge JM. Biologically relevant metal ion dependent hydroxyl radical generation. An update FEBS Lett. 1992;307:108–12.View ArticlePubMedGoogle Scholar
- Su XY, Liu PD, Wu H, Gu N. Enhancement of radiosensitization by metal-based nanoparticles in cancer radiation therapy. Cancer Biol Med. 2014;11(2):86–91.PubMedPubMed CentralGoogle Scholar
- Conde J, Doria G, Baptista P. Noble metal nanoparticles applications in cancer. J Drug Deliv. 2012;2012:751075.View ArticlePubMedGoogle Scholar
- Al Zaki A, Joh D, Cheng Z, De Barros AL, Kao G, Dorsey J, et al. Gold-loaded polymeric micelles for computed tomography-guided radiation therapy treatment and radiosensitization. ACS Nano. 2014;8(1):104–12.View ArticlePubMedGoogle Scholar
- Misawa M, Takahashi J. Generation of reactive oxygen species induced by gold nanoparticles under x-ray and UV Irradiations. Nanomedicine. 2011;7:604–14.PubMedGoogle Scholar
- Geng F, Song K, Xing JZ, Yuan C, Yan S, Yang Q, et al. Thio-glucose bound gold nanoparticles enhance radio-cytotoxic targeting of ovarian cancer. Nanotechnology. 2011;22:285101.View ArticlePubMedGoogle Scholar
- Ngwa W, Kumar R, Sridhar S, Korideck H, Zygmanski P, Cormack RA, et al. Targeted radiotherapy with gold nanoparticles: current status and future perspectives. Nanomedicine (Lond). 2014;9(7):1063–82.View ArticleGoogle Scholar
- Hainfeld JF, Smilowitz HM, O’Connor MJ, Dilmanian FA, Slatkin DN. Gold nanoparticle imaging and radiotherapy of brain tumors in mice. Nanomedicine (Lond). 2013;8:1601–9.View ArticleGoogle Scholar
- Joh DY, Sun L, Stangl M, Al Zaki A, Murty S, Santoiemma PP, et al. Selective targeting of brain tumors with gold nanoparticle-induced radiosensitization. PLoS One. 2013;8(4), e62425.View ArticlePubMedPubMed CentralGoogle Scholar
- Balasubramanian SK, Jittiwat J, Manikandan J, Ong CN, Yu LE, Ong WY. Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats. Biomaterials. 2010;31:2034–42.View ArticlePubMedGoogle Scholar
- Sadauskas E, Danscher G, Stoltenberg M, Vogel U, Larsen A, Wallin H. Protracted elimination of gold nanoparticles from mouse liver. Nanomedicine. 2009;5:162–9.PubMedGoogle Scholar
- Hainfeld JF, Slatkin DN, Smilowitz HM. The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol. 2004;49:N309–15.View ArticlePubMedGoogle Scholar
- Chang MY, Shiau AL, Chen YH, Chang CJ, Chen HH, Wu CL. Increased apoptotic potential and dose-enhancing effect of gold nanoparticles in combination with single-dose clinical electron beams on tumor-bearing mice. Cancer Sci. 2008;99:1479–84.View ArticlePubMedGoogle Scholar